Alcon Vision LLC

Spending by Year

Lobbying Firms

What They Lobby For

• Federal regulatory and reimbursement policies relating to eye care services, medicines and medical technologies
• S. 692, the Protect Medical Innovation Act H.R. 2207, the Protect Medical Innovation Act
• Federal regulatory and reimbursement policies relating to eye care services, medicines and medical technologies; H.R. 2113, the Prescription Drug Sunshine, Transparency, Accountability and Reporting Act, including medical device product samples reporting; H.R. 2296, the FAIR Drug Pricing Act, including medical device product samples reporting
• Implementation issues relating to Public Law No. 113-146, the Veterans Access, Choice and Accountability Act, including provider reimbursement policies
• Federal regulatory and reimbursement policies relating to eye care services, medicines and medical technologies. H.R. 2113, the Prescription Drug Sunshine, Transparency, Accountability and Reporting Act, including medical device product samples reporting. H.R. 2296, the FAIR Drug Pricing Act, including medical device product samples reporting. H.R. 3, the Lower Drug Costs Now Act. S. 2543, the Prescription Drug Price Reduction Act.
• Implementation issues relating to Public Law No. 113-146, the Veterans Access, Choice and Accountability Act, including provider reimbursement policies.
• H.R. 1865, the Further Consolidated Appropriations Act, 2020, specifically Section 501, repeal of the medical device excise tax. H.R. 2207, the Protect Medical Innovation Act. S. 692, the Protect Medical Innovation Act.
• Federal regulatory and reimbursement policies relating to eye care services, medicines and medical technologies. H.R. 3, the Lower Drug Costs Now Act. H.R. 19, the Lower Costs, More Cures Act. H.R. 1393, the Medicare Dental, Vision, and Hearing Benefit Act. H.R. 1865, the Further Consolidated Appropriations Act, 2020, specifically Section 501, repeal of the medical device excise tax. H.R. 2113, the Prescription Drug Sunshine, Transparency, Accountability and Reporting Act, including medical device product samples reporting. H.R. 2296, the FAIR Drug Pricing Act, including medical device product samples reporting. H.R. 3975, the Contact Lens Prescription Verification Modernization Act. H.R. 3762, the Dental and Optometric Care Access Act. H.R. 4665, the Medicare Vision Act. S. 1423, the Medicare and Medicaid Dental, Vision, and Hearing Benefit Act. S. 2543, the Prescription Drug Price Reduction Act. S. 3129, the Lower Costs, More Cures Act.
• Federal regulatory and reimbursement policies relating to eye care services, medicines and medical technologies. H.R.1393, the Medicare Dental, Vision, and Hearing Benefit Act. H.R. 4665, the Medicare Vision Act. S. 1423, the Medicare and Medicaid Dental, Vision, and Hearing Benefit Act.
• Federal regulatory and reimbursement policies relating to eye care services, medicines and medical technologies. H.R. 3, the Lower Drug Costs Now Act. H.R. 19, the Lower Costs, More Cures Act. H.R. 1393, the Medicare Dental, Vision, and Hearing Benefit Act. H.R. 2113, the Prescription Drug Sunshine, Transparency, Accountability and Reporting Act, including medical device product samples reporting. H.R. 2296, the FAIR Drug Pricing Act, including medical device product samples reporting. H.R. 3975, the Contact Lens Prescription Verification Modernization Act. H.R. 3762, the Dental and Optometric Care Access Act. H.R. 4665, the Medicare Vision Act. S. 1423, the Medicare and Medicaid Dental, Vision, and Hearing Benefit Act. S. 2543, the Prescription Drug Price Reduction Act. S. 3129, the Lower Costs, More Cures Act.

Related Investigations

Explore More